Cutler Group’s Antares Pharma, Inc. ATRS Stock Holding History

Cutler Group’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-7,786	Closed	-$31K	–	6041
2022 Q1	$31K	Buy	+7,786	New	+$28.2K	﹤0.01%	2683
2017 Q2	–	Sell	-1,061	Closed	-$3K	–	7364
2017 Q1	$3K	Hold	1,061	–	–	﹤0.01%	5276
2016 Q4	$2K	Hold	1,061	–	–	﹤0.01%	5770
2016 Q3	$1K	Hold	1,061	–	–	﹤0.01%	6400
2016 Q2	$1K	Hold	1,061	–	–	﹤0.01%	6383
2016 Q1	$0	Hold	1,061	–	–	﹤0.01%	7445
2015 Q4	$1K	Buy	+1,061	New	+$1.48K	﹤0.01%	6177

Other funds holding ATRS

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Cutler Group's ATRS Position: Q2 2022 in Review

Cutler Group sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 7,786 shares — an estimated $31K sold.

Cutler Group first reported a position in ATRS in Q4 2015 and held it in 7 quarters. The position peaked at $31K in Q1 2022. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

Cutler Group reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
Cutler Group sold 7,786 Antares Pharma, Inc. shares in Q2 2022, an estimated $31K.
Cutler Group first reported a position in Antares Pharma, Inc. in Q4 2015 and held it in 7 quarters.
Cutler Group's Antares Pharma, Inc. position peaked at $31K in Q1 2022.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Cutler Group's 13F filing for Q2 2022, filed 4 Aug 2022.